amphetamine has been researched along with quinoxalines in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (63.16) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 2 (10.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kunow, M; Löschmann, PA; Wachtel, H | 1 |
| Boldry, RC; Uretsky, NJ; Wallace, LJ; Willins, DL | 1 |
| Calder, LD; Karler, R; Turkanis, SA | 1 |
| Cannon-Spoor, HE; Freed, WJ | 1 |
| Zvartau, EE | 1 |
| Bedingfield, JB; Calder, LD; Karler, R; Thai, LH | 1 |
| Layer, RT; Uretsky, NJ; Wallace, LJ | 1 |
| Bedingfield, JB; Calder, LD; Karler, R | 1 |
| Dalia, A; Uretsky, NJ; Wallace, LJ | 1 |
| Li, Y; Vartanian, AJ; White, FJ; Wolf, ME; Xue, CJ | 1 |
| Mead, AN; Stephens, DN | 2 |
| Glick, SD; Maisonneuve, IM; Shoblock, JR; Sullivan, EB | 1 |
| Greenshaw, AJ; Mosher, TM; Smith, JG | 1 |
| Billing, CB; Burstein, AH; McColl, SL; Reeves, KR; Sellers, EM; Stolar, M | 1 |
| Booth, RG; Crump, EM; Nguyen, N; Robertson, K; Rowland, NE; Sun, Z | 1 |
| Greenshaw, AJ; Hayes, DJ; Mosher, TM | 1 |
| Gnegy, ME; Jutkiewicz, EM; Kim, MN; Zhang, M | 1 |
| Coccurello, R; Mele, A; Oliverio, A | 1 |
1 trial(s) available for amphetamine and quinoxalines
| Article | Year |
|---|---|
Human abuse liability of the smoking cessation drug varenicline in smokers and nonsmokers.
Topics: Adult; Amphetamine; Benzazepines; Central Nervous System Stimulants; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Multivariate Analysis; Nicotinic Agonists; Odds Ratio; Quinoxalines; Reproducibility of Results; Smoking; Smoking Cessation; Substance-Related Disorders; Surveys and Questionnaires; Varenicline | 2008 |
18 other study(ies) available for amphetamine and quinoxalines
| Article | Year |
|---|---|
NBQX (6-nitro-sulfamoyl-benzo-quinoxaline-dione) and CPP (3-carboxy-piperazin-propyl phosphonic acid) potentiate dopamine agonist induced rotations in substantia nigra lesioned rats.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amphetamine; Animals; Apomorphine; Dopamine Agents; Drug Synergism; Ibotenic Acid; Lisuride; Male; Neurons; Oxidopamine; Parkinson Disease, Secondary; Piperazines; Quinoxalines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Stereotyped Behavior; Substantia Nigra; Sympathectomy, Chemical | 1992 |
The role of endogenous dopamine in the hypermotility response to intra-accumbens AMPA.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; alpha-Methyltyrosine; Amphetamine; Animals; Benzazepines; Dialysis; Dopamine; Dopamine Antagonists; Ibotenic Acid; Injections; Male; Methyltyrosines; Motor Activity; Nucleus Accumbens; Quinoxalines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Stimulation, Chemical; Sulpiride; Synaptic Transmission; Tyrosine 3-Monooxygenase | 1991 |
DNQX blockade of amphetamine behavioral sensitization.
Topics: Amphetamine; Analysis of Variance; Animals; Dose-Response Relationship, Drug; Haloperidol; Kainic Acid; Male; Mice; Mice, Inbred Strains; N-Methylaspartate; Quinoxalines; Seizures; Stereotyped Behavior | 1991 |
A possible role of AA2 excitatory amino acid receptors in the expression of stimulant drug effects.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Amino Acids; Amphetamine; Animals; Apomorphine; Behavior, Animal; Central Nervous System Stimulants; Dibenzocycloheptenes; Dizocilpine Maleate; Dose-Response Relationship, Drug; Female; Glutamates; Mice; Motor Activity; Phencyclidine; Quinoxalines; Receptors, Amino Acid; Receptors, Cell Surface; Stereotyped Behavior | 1990 |
Subchronic morphine increases amphetamine-induced potentiation of brain stimulation reward: reversal by DNQX.
Topics: Amphetamine; Animals; Behavior, Animal; Conditioning, Operant; Glutamic Acid; Male; Morphine; Prosencephalon; Quinoxalines; Rats; Rats, Inbred Strains; Reward; Time Factors | 1995 |
A dopaminergic-glutamatergic basis for the action of amphetamine and cocaine.
Topics: Amphetamine; Animals; Cocaine; Corpus Striatum; Dizocilpine Maleate; Male; Mice; Piperazines; Quinoxalines; Receptors, Dopamine; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Stereotyped Behavior; Sulpiride | 1994 |
Effects of the AMPA/kainate receptor antagonist DNQX in the nucleus accumbens on drug-induced conditioned place preference.
Topics: Amphetamine; Animals; Choice Behavior; Conditioning, Operant; Male; Morphine; Nucleus Accumbens; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA | 1993 |
Comparative behavioral sensitization to stereotypy by direct and indirect dopamine agonists in CF-1 mice.
Topics: Amphetamine; Animals; Apomorphine; Cocaine; Diltiazem; Dopamine Agonists; Drug Interactions; Fluoresceins; Male; Mice; Quinoxalines; Stereotyped Behavior | 1996 |
Induction of locomotor activity by the glutamate antagonist DNQX injected into the ventral tegmental area.
Topics: Amphetamine; Animals; Excitatory Amino Acid Antagonists; Locomotion; Male; Quinoxalines; Rats; Rats, Sprague-Dawley; Ventral Tegmental Area | 1996 |
Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine.
Topics: Amphetamine; Animals; Behavior, Animal; Cocaine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Male; Motor Activity; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Stereotyped Behavior | 1997 |
AMPA-receptors are involved in the expression of amphetamine-induced behavioural sensitisation, but not in the expression of amphetamine-induced conditioned activity in mice.
Topics: Amphetamine; Animals; Behavior, Animal; Conditioning, Classical; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Motor Activity; Quinoxalines; Receptors, AMPA | 1998 |
CNQX but not NBQX prevents expression of amphetamine-induced place preference conditioning: a role for the glycine site of the NMDA receptor, but not AMPA receptors.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Amphetamine; Animals; Central Nervous System Stimulants; Conditioning, Operant; Excitatory Amino Acid Antagonists; Male; Mice; Mice, Inbred C57BL; Motor Activity; Quinolones; Quinoxalines; Receptors, AMPA; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate | 1999 |
Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Behavior, Animal; Brain Chemistry; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Homovanillic Acid; Methamphetamine; Microdialysis; Motor Activity; Nucleus Accumbens; Prefrontal Cortex; Quinoxalines; Rats; Rats, Sprague-Dawley; Time Factors; Valine | 2003 |
Aversive stimulus properties of the 5-HT2C receptor agonist WAY 161503 in rats.
Topics: Amphetamine; Analysis of Variance; Animals; Avoidance Learning; Behavior, Animal; Conditioning, Psychological; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Food Preferences; Male; Pyrazines; Quinoxalines; Rats; Rats, Sprague-Dawley; Retention, Psychology; Saccharin; Serotonin 5-HT2 Receptor Agonists; Sweetening Agents; Time Factors | 2006 |
Effect of (-)-trans-PAT, a novel 5-HT2C receptor agonist, on intake of palatable food in mice.
Topics: Amphetamine; Animals; Appetite Depressants; Catecholamines; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Eating; Female; Food Preferences; Mice; Mice, Inbred C57BL; Pyrazines; Quinoxalines; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists; Tetrahydronaphthalenes | 2008 |
Differential effects of 5-HT2C receptor activation by WAY 161503 on nicotine-induced place conditioning and locomotor activity in rats.
Topics: Aminopyridines; Amphetamine; Animals; Conditioning, Operant; Dopamine Agents; Dose-Response Relationship, Drug; Indoles; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Motor Activity; Nicotine; Nicotinic Agonists; Pyrazines; Quinoxalines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Reward; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2009 |
The sensitizing effect of acute nicotine on amphetamine-stimulated behavior and dopamine efflux requires activation of β2 subunit-containing nicotinic acetylcholine receptors and glutamate N-methyl-D-aspartate receptors.
Topics: Aconitine; Amphetamine; Animals; Behavior, Animal; Benzazepines; Central Nervous System Stimulants; Dizocilpine Maleate; Dopamine; Excitatory Amino Acid Antagonists; Female; Male; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic; Varenicline | 2011 |
Impairing effect of amphetamine and concomitant ionotropic glutamate receptors blockade in the ventral striatum on spatial learning in mice.
Topics: 2-Amino-5-phosphonovalerate; Amphetamine; Animals; Basal Ganglia; Dopamine; Dose-Response Relationship, Drug; Exploratory Behavior; Male; Mice; Quinoxalines; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 2013 |